Intellia Therapeutics Inc.

Frank A. G. M. Verwiel is a Dutch businessperson who has been at the head of 6 different companies and holds the position of Chairman for Intellia Therapeutics, Inc. and President at Aptalis Pharma US, Inc. Dr. Verwiel is also on the board of Bavarian Nordic An and Bavarian Nordic GmbH.

Dr. Verwiel previously held the position of Chairman at ObsEva SA, VP-Hypertension & Worldwide Human Health Marketing at Merck & Co., Inc., President, Chief Executive Officer & Director at Aptalis Pharma, Inc., President & Chief Executive Officer at TA SASU, President, Chief Executive Officer & Director at Aptalis Holdings, Inc. and Director & Director-Health Section Governing Board at Biotechnology Innovation Organization.

Dr. Verwiel received an MBA from INSEAD and a doctorate from Erasmus University Rotterdam.